|
KR102775461B1
(ko)
|
2016-04-01 |
2025-02-28 |
어비디티 바이오사이언시스 인크. |
핵산-폴리펩타이드 조성물 및 이의 용도
|
|
CN118638787A
(zh)
|
2017-12-06 |
2024-09-13 |
艾维迪提生物科学公司 |
治疗肌萎缩和强直性肌营养不良的组合物和方法
|
|
US12097263B2
(en)
|
2018-08-02 |
2024-09-24 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
CA3108386A1
(en)
*
|
2018-08-02 |
2020-02-06 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating friedreich's ataxia
|
|
US11911484B2
(en)
|
2018-08-02 |
2024-02-27 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
AU2019315593B2
(en)
*
|
2018-08-02 |
2026-05-21 |
Dyne Therapeutics, Inc. |
Muscle-targeting complexes and uses thereof
|
|
WO2020028832A1
(en)
|
2018-08-02 |
2020-02-06 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating dystrophinopathies
|
|
US12018087B2
(en)
|
2018-08-02 |
2024-06-25 |
Dyne Therapeutics, Inc. |
Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject
|
|
US11168141B2
(en)
|
2018-08-02 |
2021-11-09 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating dystrophinopathies
|
|
US12370264B1
(en)
|
2018-08-02 |
2025-07-29 |
Dyne Therapeutics, Inc. |
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject
|
|
EP3830259A4
(en)
|
2018-08-02 |
2022-05-04 |
Dyne Therapeutics, Inc. |
MUSCLE TARGETED COMPLEXES AND THEIR USES IN THE TREATMENT OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
|
|
EP4087653A4
(en)
*
|
2020-01-10 |
2024-06-19 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
WO2021154477A1
(en)
|
2020-01-31 |
2021-08-05 |
Dyne Therapeutics, Inc. |
Anti-transferrin receptor (tfr) antibody and uses thereof
|
|
KR102927945B1
(ko)
|
2020-03-27 |
2026-02-23 |
어비디티 바이오사이언시스 인크. |
근이영양증의 치료용 조성물 및 방법
|
|
US20230330246A1
(en)
*
|
2020-05-05 |
2023-10-19 |
Avidity Biosciences, Inc. |
Compositions and methods of treating pompe disease
|
|
WO2021226454A1
(en)
*
|
2020-05-08 |
2021-11-11 |
Mpeg La, L.L.C. |
Linker compounds
|
|
MX2023000984A
(es)
*
|
2020-07-23 |
2023-05-03 |
Dyne Therapeutics Inc |
Complejos dirigidos al musculo y usos de los mismos para el tratamiento de distrofinopatias.
|
|
US11638761B2
(en)
|
2021-07-09 |
2023-05-02 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy
|
|
US11633498B2
(en)
|
2021-07-09 |
2023-04-25 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
MX2023000958A
(es)
*
|
2020-07-23 |
2023-04-14 |
Dyne Therapeutics Inc |
Complejos dirigidos al musculo y usos de estos para el tratamiento de la distrofia miotonica.
|
|
US11672872B2
(en)
|
2021-07-09 |
2023-06-13 |
Dyne Therapeutics, Inc. |
Anti-transferrin receptor antibody and uses thereof
|
|
AU2021313058A1
(en)
*
|
2020-07-23 |
2023-03-30 |
Dyne Therapeutics, Inc. |
Muscle-targeting complexes and uses thereof
|
|
US11771776B2
(en)
|
2021-07-09 |
2023-10-03 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating dystrophinopathies
|
|
US11969475B2
(en)
|
2021-07-09 |
2024-04-30 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
|
|
KR20230117182A
(ko)
*
|
2020-12-04 |
2023-08-07 |
다인 세라퓨틱스, 인크. |
항체-올리고뉴클레오티드 복합체 및 그의 용도
|
|
AU2021414227A1
(en)
*
|
2020-12-31 |
2023-07-06 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
WO2022197554A1
(en)
*
|
2021-03-16 |
2022-09-22 |
University Of Massachusetts |
Photocaged citrulline analogs and methods for site-specific incorporation of citrulline into proteins
|
|
EP4359534A4
(en)
*
|
2021-06-21 |
2026-07-22 |
Dyne Therapeutics Inc |
MUSCLE TARGETTING COMPLEXES AND THEIR USES IN THE TREATMENT OF POMPE DISEASE
|
|
CA3222816A1
(en)
*
|
2021-06-21 |
2022-12-29 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating friedreich's ataxia
|
|
CA3226301A1
(en)
*
|
2021-07-09 |
2023-01-12 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
|
|
JP2024525613A
(ja)
*
|
2021-07-09 |
2024-07-12 |
ダイン セラピューティクス，インコーポレーテッド |
筋標的化複合体およびジストロフィノパチーを処置するためのその使用
|
|
WO2023283623A1
(en)
|
2021-07-09 |
2023-01-12 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and formulations for treating dystrophinopathies
|
|
EP4366774A4
(en)
*
|
2021-07-09 |
2025-11-19 |
Dyne Therapeutics Inc |
MUSCLE TARGETTING COMPLEXES AND THEIR USES FOR MODULATING GENES ASSOCIATED WITH MUSCLE HEALTH
|
|
US20240318176A1
(en)
*
|
2021-07-09 |
2024-09-26 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for treating dystrophinopathies
|
|
WO2023023031A2
(en)
*
|
2021-08-17 |
2023-02-23 |
Blaze Bioscience, Inc. |
Transferrin receptor targeting peptide oligonucleotide complexes and methods of use thereof
|
|
CA3230796A1
(en)
|
2021-09-01 |
2023-03-09 |
Biogen Ma Inc. |
Anti-transferrin receptor antibodies and uses thereof
|
|
KR20240067118A
(ko)
*
|
2021-09-29 |
2024-05-16 |
아이오니스 파마수티컬즈, 인코포레이티드 |
접합된 올리고뉴클레오타이드 및 이의 용도
|
|
CA3240612A1
(en)
|
2021-12-22 |
2023-06-29 |
Miriam Verena Bujny |
Targeted saponin-nucleic acid conjugates for treatment of muscle wasting disorders
|
|
US20250082759A1
(en)
|
2021-12-22 |
2025-03-13 |
Sapreme Technologies B.V. |
Compositions comprising therapeutic nucleic acid and targeted saponin for the treatment of muscle-wasting disorders
|
|
EP4452281A1
(en)
|
2021-12-22 |
2024-10-30 |
Sapreme Technologies B.V. |
Compositions comprising therapeutic nucleic acid and saponin for the treatment of muscle-wasting disorders
|
|
IL314093A
(en)
*
|
2022-01-07 |
2024-09-01 |
Mirecule Inc |
Agents used for tissue-specific imaging and as therapeutic agents targeting proteins expressed on the surface of muscle cells
|
|
IL316143A
(en)
|
2022-04-15 |
2024-12-01 |
Dyne Therapeutics Inc |
Muscle targeting complexes and formulations for the treatment of myotonic dystrophy
|
|
AU2023371614A1
(en)
*
|
2022-11-04 |
2025-05-15 |
Regeneron Pharmaceuticals, Inc. |
Calcium voltage-gated channel auxiliary subunit gamma 1 (cacng1) binding proteins and cacng1-mediated delivery to skeletal muscle
|
|
EP4480964A1
(en)
*
|
2023-06-22 |
2024-12-25 |
Vect-Horus |
Transferrin receptor-binding molecules, conjugates thereof and their uses to prevent or treat muscular diseases
|
|
WO2024261332A2
(en)
*
|
2023-06-22 |
2024-12-26 |
Vect-Horus |
Transferrin receptor-binding molecules, conjugates thereof and their uses to prevent or treat muscular diseases
|
|
US12527877B2
(en)
|
2024-01-24 |
2026-01-20 |
Arrowhead Pharmaceuticals, Inc. |
Anti-transferrin receptor antibodies, conjugates thereof, and uses thereof
|